Advertisement
Singapore markets open in 1 hour 11 minutes

  • Straits Times Index

    3,316.56
    -6.06 (-0.18%)
     

  • S&P 500

    5,304.72
    +36.88 (+0.70%)
     

  • Dow

    39,069.59
    +4.29 (+0.01%)
     

  • Nasdaq

    16,920.79
    +184.79 (+1.10%)
     

  • Bitcoin USD

    68,494.30
    -747.38 (-1.08%)
     

  • CMC Crypto 200

    1,481.06
    +12.96 (+0.88%)
     

  • FTSE 100

    8,317.59
    -21.64 (-0.26%)
     

  • Gold

    2,339.00
    +4.50 (+0.19%)
     

  • Crude Oil

    77.80
    +0.08 (+0.10%)
     

  • 10-Yr Bond

    4.4670
    -0.0080 (-0.18%)
     

  • Nikkei

    38,646.11
    -457.09 (-1.17%)
     

  • Hang Seng

    18,608.94
    -259.76 (-1.38%)
     

  • FTSE Bursa Malaysia

    1,619.40
    -9.78 (-0.60%)
     

  • Jakarta Composite Index

    7,222.38
    -7,186.04 (-49.87%)
     

  • PSE Index

    6,619.89
    -40.10 (-0.60%)
     

Ginkgo Bioworks Announces Date of First Quarter 2024 Results Presentation

PR Newswire
·1-min read

Presentation and Q&A session scheduled for post-market on Thursday, May 9, 2024

BOSTON, May 2, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business performance for the first quarter ended March 31, 2024, on Thursday, May 9, 2024, beginning at 5:30 p.m. ET.

(PRNewsfoto/Ginkgo Bioworks)
(PRNewsfoto/Ginkgo Bioworks)

The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.

ADVERTISEMENT

To ask a question ahead of the presentation, please submit them to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.

About Ginkgo Bioworks

Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks) or LinkedIn.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:

investors@ginkgobioworks.com

MEDIA CONTACT:

press@ginkgobioworks.com

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-first-quarter-2024-results-presentation-302133477.html

SOURCE Ginkgo Bioworks